AxoGen, Inc. Uncategorized Contracts & Agreements
11 Contracts & Agreements
- Description of Securities of Axogen, Inc (Filed With SEC on February 24, 2020)
- Current Premises Election Notice dated as of April 10, 2018 (Filed With SEC on April 13, 2018)
- FOURTH AMENDMENT TO AMENDED AND RESTATED NERVE TISSUE PROCESSING AGREEMENT (Filed With SEC on November 13, 2014)
- INTERIM REVENUE INTERESTSPURCHASE AGREEMENT Dated as of August 14, 2012 between AxoGen, Inc. and PDLBioPharma, Inc. Table of Contents (Filed With SEC on November 6, 2012)
- THIRD AMENDMENT TO AMENDED AND RESTATED NERVE TISSUE PROCESSING AGREEMENT (Filed With SEC on March 15, 2012)
- AXOGEN AMENDED AND RESTATED NERVE TISSUE PROCESSING AGREEMENT (Filed With SEC on January 25, 2012)
- SECOND AMENDMENT TO AMENDED AND RESTATED NERVE TISSUE PROCESSING AGREEMENT (Filed With SEC on October 6, 2011)
- AXOGEN AMENDED AND RESTATED NERVE TISSUE PROCESSING AGREEMENT (Filed With SEC on October 6, 2011)
- CURRENT ASSETS (Filed With SEC on November 15, 2010)
- LECTECCORPORATION NONQUALIFIEDSTOCK OPTION AGREEMENT (Filed With SEC on June 2, 2010)
- ADVISORYSERVICES AGREEMENT (Filed With SEC on June 2, 2010)